Total Funding
12
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
306241
Parcell’s platform technology has the potential to deliver a diverse portfolio of products for multiple indications.
Keith Crawford: Chief Visionary Officer- Jeffrey Gadboys: Chief Operating Officer
About the Company
Parcell Laboratories, founded in 2008, is focused on developing novel therapeutics around our unique adult stem cell platform technology, the ELA® cell. The ELA cell was discovered by scientists affiliated with the Brigham and Women’s Hospital and Harvard Medical School who demonstrated the vast potential of the technology in regenerative
medicine. ELA cells are found in various tissues throughout the body and are characterized by a specific surface marker profile that set them apart from other adult stem cells.
Women Founded
Women Led
